Trial intelligence / Profile preview

Long-Term Safety and Tolerability of Prucalopride in Chronic Constipation

NCT01070615Phase 3Completed

Sponsor
Movetis
Start
Jun 1998
Primary completion
Nov 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of prucalopride in chronic constipation, sponsored by Movetis. Started Jun 1998; status: completed.

02

Drugs

prucalopride
03

Conditions

chronic constipation

Beyond the preview

Go deeper on NCT01070615.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01070615.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call